Portal Instruments, Inc., an emerging leader in the development of innovative drug delivery systems, announced that Robert Langer, Sc.D., MIT Institute Professor, and Peter Hunter, Ph.D., University of Auckland Distinguished Professor have joined the company’s Scientific Advisory Board.

“We are thrilled to welcome two esteemed biotechnology leaders, Professor Robert Langer and Professor Peter Hunter, to our team,” said Dr. Patrick Anquetil, Chief Executive Officer of Portal Instruments. “We will benefit greatly from their combined and extensive expertise in drug delivery, physiological modeling, and medical device development, as we transition our efforts from research and development to clinical studies and future commercialization.”

Professors Langer and Hunter will join current Scientific Advisory Board Chair, Ian Hunter, Ph.D., co-founder of Portal Instruments and MIT Hatsopoulos Professor of Mechanical Engineering, as Portal continues to develop a digitally-controlled, needlefree drug injection system to simultaneously transform the delivery of modern medicines and improve the patient experience.

Anquetil continued, “We look forward to the insights and contributions Professors Langer and Hunter will make, to push our device to the next level. We believe their unique perspectives with regard to the intricacies of delivery physiology, design for inherent patient variability, and the implementation of clinical investigations will provide a strong benefit to the company.”